All Emerging Market articles – Page 29
-
White papers
Macroeconomic picture - September 2020
A new Covid-19 outbreak in several states in July and August imposed more caution in reopening the economy, slowing recovery momentum. The labour market remain distressed. In the coming quarters, the US economy is expected to continue along a gradual and progressive recovery path, underpinned by easy monetary policy and a delayed new round of fiscal support.
-
White papers
Thematics: Back to school, back to politics?
The macro-economic backdrop has improved, albeit at a slower pace more recently. The European response to the crisis has further strengthened investor sentiment. However, the political picture has changed over the summer in the US and deteriorated in emerging markets.
-
White papers
NASDAQ 100-S&P 500 Volatility Ratio at Peak Levels
The cost of NASDAQ 100 options has ballooned relative to S&P 500 options over the past three years as the tech-heavy index leads the recovery in equities. Read the latest article from CME Group Senior Economist, Erik Norland.
-
White papers
Global Investment Views – September 2020
The appetite for risk assets has remained strong over the summer lull. This summer season has seen both the confirmation of existing themes and the emergence of new ones. On the former, the decoupling between the real economy and financial markets has proved persistent.
-
White papers
Impact Opportunities: H1 2020 Report
A concentrated, fundamental global equity strategy, the Federated Hermes Impact Opportunities Equity Fund seeks to generate value by investing in companies that create positive, sustainable change and strong long-term investment returns.
-
White papers
Nowcasting the US Economy with Alternative Data
The pandemic has altered some consumer and business behavioral patterns in major and likely long-lasting ways, and it is critical to track these behavioral changes and assess whether they could last or whether there will be a return to pre-pandemic habits and patterns.
-
White papers
Debunking the Myths of “High-Priced” Tech Stocks
Technology stocks seem unstoppable. Giants like Apple and Microsoft, as well as technology-driven consumer firms such as Amazon and Alibaba Group, continue to do well through the COVID-19 pandemic.
-
White papers
Growth versus Value: Balancing the Risks
Across Europe, measures implemented to contain the Covid-19 pandemic are being gradually lifted. The infection rates on the continent show different dynamics with some exceptions. At the same time, the capital markets are recovering. Therefore, we are currently at the crossroads between crisis and recovery.
-
White papers
China: 6 reasons why - it poses a unique portfolio optimisation opportunity now
The second largest economy globally – China – is forecast to overtake the United States as the world’s largest economy by 2030
-
White papers
Taking stock of the markets
Back in the old days it might be said that investing was simple. You just put some money into a company, a commodity or a piece of property, and with a bit of luck, time and reasonable management, the value of your investment went up.
-
White papers
Global Equity ESG: H1 2020 Report
Combining attractive fundamentals and good or improving environmental, social and governance (ESG) characteristics, the Federated Hermes Global Equity ESG Fund targets innovative companies that anticipate tomorrow’s challenges today.
-
White papers
Style Tilt: Growth Surge Reshapes US Stock Market in 2020
During the coronavirus downturn and rebound, US growth stocks outpaced value stocks by a record margin. Now growth stocks seem expensive, but that depends on how you look at it. So are these trends likely to continue—and how should investors position across different equity styles?
-
White papers
Fundamentals: the case for US SMID
Slow and steady wins the race. So goes the age old saying from the fable of the tortoise and the hare. But how does it apply to US small and mid-cap (SMID) companies? And is the asset class underappreciated by industry analysts? We explore the universe of US SMID companies in Fundamentals.
-
White papers
The Glass Is Still Half Full (For Now)
World economies have rebounded from lockdowns faster than expected despite much differentiation among them. Much still depends on further progress in managing COVID-19 and continuing policy stimulus.
-
White papers
Hong Kong-China Equities: Accelerating Areas of Opportunity
As COVID-19 slowly loosens its grip on China, it has become clear that many of the long-term structural trends shaping the markets remain intact or have even accelerated—creating investment opportunities in Hong Kong-China equities.
-
White papers
Keep Your Eye on the Loser
The election’s winner will drive market sentiment for the next several months, but the loser could reshape economic policy for the decade.
-
White papers
European equities: accelerating the digital revolution
The coronavirus crisis has fast-tracked the global economy’s digital transition, as the pandemic has encouraged the uptake of virtual solutions across different industries.
-
White papers
Global Emerging Markets: ESG Materiality, Q3 2020
Welcome to the Global Emerging Markets’ ESG Materiality commentary – a quarterly publication that demonstrates our engagement activity with portfolio companies and showcases holdings that are creating positive impact aligned to the Sustainable Development Goals. In addition, we explore an environmental, social and governance (ESG) theme and its implications for the asset class.
-
White papers
Recovering scenarios and Emerging Themes
Erik Knutzen shares guidance on navigating the range of paths through the recovery and our Playbook 2.0 for capitalizing on investment themes.
-
White papers
Is Concentrated Investing Riskier in Today’s Uncertain Environment?
In a world of increased uncertainty, many investors’ natural instinct is to “hedge their bets” by diversifying, rather than investing in a concentrated strategy. But this year, a portfolio consisting of just the five largest US stocks would have significantly outperformed. So, is there a way to reduce risk and to capture long-term growth in a concentrated portfolio?